Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 10.2.2023MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))30.1.2023O
 10.2.2023MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))6.2.2023R
 10.2.2023MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))16.1.2023O
 10.2.2023MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))28.11.2022R
 10.2.2023MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))15.2.2023O
 10.2.2023MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))14.11.2022O
 10.2.2023MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))30.1.2023R
 10.2.2023MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))23.1.2023R
 10.2.2023MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))16.1.2023O
 10.2.2023MEDOCHEMIE Ltd. (MOE)9445BZEPILEN 1 g (plo ijf 10x1 g (liek.inj.skl.))30.1.2023O
 10.2.2023MEDOCHEMIE Ltd. (MOE)9445BZEPILEN 1 g (plo ijf 10x1 g (liek.inj.skl.))8.2.2023R
 10.2.2023CZ Pharma s.r.o. (CZP)9837DAmoxicillin/Clavulanic Acid Olikla 1 000 mg/200 mg prášok na injekčný/infúzny roztok (plo ijf 50x20 ml (liek.inj.skl.))14.2.2023U
 10.2.2023Mylan Pharmaceuticals Limited (MLB-IE-1)4035BTadalafil Mylan 20 mg filmom obalené tablety (tbl flm 4x20 mg (PVC/PE/PVDC/Al))28.2.2023Z
 10.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)15868Zinnat 125 mg (tbl flm 10x125 mg (blis.OPA/Al/PVC))26.1.2023R
 10.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)15869Zinnat 250 mg (tbl flm 10x250 mg (blis.OPA/Al/PVC))26.1.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)